Typical and atypical neuroleptics: differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons
Authors:
- LA ChiodoLCLA Chiodo
- Bs BunneyBBBs Bunney
Open Access
- 1 August 1983
- journal article
- Published by Society for Neuroscience in Journal of Neuroscience
- Vol. 3 (8) , 1607-1619
Abstract
Extracellular single unit recording techniques were used to study the effects of both acute and repeated oral neuroleptic administration on the in vivo activity of rat A9 and A10 dopaminergic (DA) neurons. All antipsychotic drugs examined acutely (haloperidol, l-sulpiride, chlorpromazine, and clozapine) increased the number of spontaneously firing DA neurons in both A9 and A10 compared to controls. Repeated (21 day) treatment with haloperidol, l-sulpiride, and chlorpromazine (antipsychotic drugs which can cause extrapyramidal side effects) markedly reduced the number of active DA cells below control levels in both regions. The “silent” DA neurons were in an apparent state of tonic depolarization inactivation since they could be induced to discharge by the microiontophoretic application of the inhibitory neurotransmitter gamma-aminobutyric acid, but not the excitatory amino acid glutamate. The depolarization inactivation observed may be specific for antipsychotic drugs since a non-neuroleptic phenothiazine (promethazine), the inactive isomer of sulpiride (d-sulpiride), and a tricyclic antidepressant (desmethylimipramine) neither increased DA activity when given acutely nor induced depolarization inactivation when administered repeatedly. In contrast to the other drugs tested, repeated treatment with clozapine (an effective antipsychotic drug which does not produce extrapyramidal side effects) resulted in the depolarization inactivation of A10 neurons but not A9 cells. These data suggest that neuroleptics which can induce extrapyramidal side effects produce depolarization inactivation of both A9 and A10 neurons whereas antipsychotic drugs which lack this property inactivate only A10 neurons. It is suggested that the time-dependent development of A9 DA neuron inactivation induced by repeated neuroleptic treatment may provide a mechanism for understanding the delayed onset of extrapyramidal side effects often observed with these drugs.Keywords
This publication has 50 references indexed in Scilit:
- Presynaptic dopamine receptors: Insensitivity to kainic acid and the development of supersensitivity following chronic haloperidolNaunyn-Schmiedeberg's Archives of Pharmacology, 1980
- Tolerance to fluphenazine and supersensitivity to apomorphine in central dopaminergic systems after chronic fluphenazine decanoate treatmentNaunyn-Schmiedeberg's Archives of Pharmacology, 1980
- Electrophysiological properties of identified output neurons of the rat substantia nigra (pars compacta and pars reticulata): Evidences for the existence of branched neuronsExperimental Brain Research, 1978
- Dopamine ?Autoreceptors?: Pharmacological characterization by microiontophoretic single cell recording studiesNaunyn-Schmiedeberg's Archives of Pharmacology, 1977
- Specific effect of haloperidol on dopamine turnover in the frontal cortexNaunyn-Schmiedeberg's Archives of Pharmacology, 1977
- The precise localization of nigral afferents in the rat as determined by a retrograde tracing techniqueBrain Research, 1976
- Dopaminergic innervation of the rat prefrontal cortex: A fluorescence histochemical studyBrain Research, 1976
- Extrapyramidal reactions and amine metabolites in cerebrospinal fluid during haloperidol and clozapine treatment of schizophrenic patientsPsychopharmacology, 1975
- Acute and subacute effects of neuroleptics on dopamine synthesis and release in the rat striatumNaunyn-Schmiedeberg's Archives of Pharmacology, 1975
- Histochemical confirmation for dopaminergic innervation of the rat cerebral cortex after destruction of the noradrenergic ascending pathwaysBrain Research, 1974